[Bifonazole for the topical treatment of surface mycoses--progress!].
69 patients with superficial mycosis were treated with 1% Bifonazol cream once a day. 48 of them who suffered from tinea pedis interdigitalis received Bifonazol for 3 weeks, the remaining 21 patients who had superficial candidiasis applied it over a period of 4 weeks. The local tolerance of the cream has been very good. Control examinations 3 and 14 days after treatment proved 59 (89%) of all patients to be cured, i.e. 40 of those who had suffered from tinea pedis and 19 of the group with candidiasis.
D000287:Administration, Topical; D000935:Antifungal Agents / Q000627:therapeutic use*; D002179:Candidiasis, Cutaneous / Q000188:drug therapy; D003881:Dermatomycoses / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D014005:Tinea / Q000188:drug therapy; D014008:Tinea Pedis / Q000188:drug therapy
D000935:Antifungal Agents; D007093:Imidazoles; C036596:bifonazole
Bifonazol zur topischen Behandlung oberflächlicher Mykosen--ein Fortschritt!